As the US war in Afghanistan draws to a close, the Obama administration is considering expanding the number of bio weapons agents deployed in the country, a move that could trigger new legislation.
As part of a plan to prevent an “uncontrolled, indiscriminate, and deliberate attack” on US troops, the US is planning to deploy more agents in the US-led coalition fighting the Islamic State group, the Pentagon announced on Wednesday.
The administration is working on a revised draft of the 2018 National Defense Authorization Act that includes an expansion of the bio weapons program, according to a summary posted on the Department of Defense website.
The bio weapons are weapons developed by the military, which have a broad range of uses.
They can be used for biological warfare and chemical weapons, or for other lethal purposes, such as the production of anthrax or the development of biological agents for weapons or biological attack.
The Pentagon has not specified when it plans to expand the bio weapon program.
The Bio Weapons Working Group, which is comprised of members from the Department and the National Institutes of Health, has recommended increasing the number and types of biological weapons agents that are deployed in Afghanistan, according the summary.
It also calls for the use of a limited number of biological warfare munitions that can be deployed in conjunction with the US military.
“The United States is deploying more than 10,000 soldiers to the war in Iraq, and more than 30,000 troops to the Afghanistan war,” the bio warfare working group said in its report.
“We need to find ways to support the military and provide a secure environment for our troops in the event of a biological attack on US soil.
This may mean the deployment of fewer biological weapons agent agents to Afghanistan.”
The bio weapon working group also called for the development and deployment of “other bio weapons that can deliver chemical weapons or other lethal agents, including the development, testing, and use of biological agent delivery vehicles.”
The Bio Warfare Working Group said it expects the number to increase as the war continues, according a draft of its report obtained by The Associated Press.
As the wars in Iraq and Afghanistan draw to a conclusion, the draft report said the US will be deploying “multiple bio weapons agent” agents in Afghanistan.
The US military has said it plans on deploying between 4,000 and 5,000 bio weapons Agent X agents in 2019 and 2019, according its draft report.
The draft report says the US may use a limited amount of agents for biological weapons.
In a statement, the bio war working group called on Congress to “develop a comprehensive bill to protect American personnel and facilities from biological weapons attacks, and the ability to prevent and respond to such attacks.”
The draft of a new law will need to be approved by Congress, according Toobin.
The Obama administration announced in January that it would deploy more than 60,000 US troops in Afghanistan by the end of 2021.
The White House says it is considering whether to expand that deployment beyond 2021.
It said that number includes a small number of troops who are deployed as advisers and training support.
The military has deployed more than 3,800 US troops to Afghanistan, including 1,000 on the front lines and 3,200 in the area surrounding the capital city of Kabul.
The deployment of more troops comes amid a new wave of anti-US protests against the Obama presidency and its military policies.
Last month, protesters in Afghanistan stormed a US military base in the province of Paktika, killing an American soldier.